Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Potential clinical application of anti-Müllerian hormone testing in radioiodine treatment of thyroid carcinoma ; volume:17 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-5 ; date:12.2024
BMC Research Notes / Biomed Central; 17, Heft 1 (23.5.2024), 1-5, 12.2024
- Creator
-
Havlínová, Barbora
Součková, Ilona
Kopřivová, Kateřina
Doležal, Jiří
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-024-06802-y
- URN
-
urn:nbn:de:101:1-2408020922336.109500594509
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Havlínová, Barbora
- Součková, Ilona
- Kopřivová, Kateřina
- Doležal, Jiří
- SpringerLink (Online service)
Other Objects (12)
The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules
Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study
Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Evaluation of anti-Müllerian hormone in pre-menopausal women stratified according to thyroid function, autoimmunity and age
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia
Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules
Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study
Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Evaluation of anti-Müllerian hormone in pre-menopausal women stratified according to thyroid function, autoimmunity and age
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia
Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
The influence of thyroid hormone medication on intra-therapeutic half-life of 131I during radioiodine therapy of solitary toxic thyroid nodules
Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study
Testing for anti-Müllerian hormone: analytical performances and usability of a point-of-care assay
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Evaluation of anti-Müllerian hormone in pre-menopausal women stratified according to thyroid function, autoimmunity and age
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia
Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma